Literature DB >> 15138313

Hyperglycaemic crises and lactic acidosis in diabetes mellitus.

P English1, G Williams.   

Abstract

Diabetic ketoacidosis, hyperglycaemic hyperosmolar state, and lactic acidosis represent three of the most serious acute complications of diabetes. There have been some advances in our understanding of the pathogenesis of these conditions over the last three decades, together with more uniform agreement on their treatment and innovations in technology. Accordingly their incidence, morbidity, and mortality are decreasing, but at rates that fall short of our aspirations. Hyperglycaemic crises in particular remain an important cause of morbidity and mortality in diabetic populations around the world. In this article, understanding of these conditions and advances in their management, and the available guidelines for their treatment, are reviewed. As far as is possible, the recommendations are based on clear published evidence; failing that, what is considered to be a common sense synthesis of consensus guidelines and recommendations is provided.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138313      PMCID: PMC1742991          DOI: 10.1136/pgmj.2002.004291

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  74 in total

Review 1.  Management of hyperglycemic crises in patients with diabetes.

Authors:  A E Kitabchi; G E Umpierrez; M B Murphy; E J Barrett; R A Kreisberg; J I Malone; B M Wall
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

Review 2.  Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause?

Authors:  J A Edge
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

3.  Hyperglycemic crises in patients with diabetes mellitus.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; Mary Beth Murphy; Eugene J Barrett; Robert A Kreisberg; John I Malone; Barry M Wall
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

4.  Clinical and metabolic characteristics of hyperosmolar nonketotic coma.

Authors:  J E Gerich; M M Martin; L Recant
Journal:  Diabetes       Date:  1971-04       Impact factor: 9.461

5.  Use of base in the treatment of severe acidemic states.

Authors:  J A Kraut; I Kurtz
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

Review 6.  Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis.

Authors:  S M Green; S G Rothrock; J D Ho; R D Gallant; R Borger; T L Thomas; G J Zimmerman
Journal:  Ann Emerg Med       Date:  1998-01       Impact factor: 5.721

7.  Abdominal pain in patients with hyperglycemic crises.

Authors:  Guillermo Umpierrez; Amado X Freire
Journal:  J Crit Care       Date:  2002-03       Impact factor: 3.425

8.  Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics.

Authors:  N Glaser; P Barnett; I McCaslin; D Nelson; J Trainor; J Louie; F Kaufman; K Quayle; M Roback; R Malley; N Kuppermann
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

Review 9.  Metformin-associated lactic acidosis: case reports and literature review.

Authors:  Chin-Tung Chang; Yung-Chang Chen; Ji-Tseng Fang; Chiu-Ching Huang
Journal:  J Nephrol       Date:  2002 Jul-Aug       Impact factor: 3.902

10.  A mortality prediction model in diabetic ketoacidosis.

Authors:  Stamatis P Efstathiou; Aphrodite G Tsiakou; Dimitrios I Tsioulos; Ioannis D Zacharos; Athanasios G Mitromaras; Stylianos E Mastorantonakis; Themistoklis N Panagiotou; Theodore D Mountokalakis
Journal:  Clin Endocrinol (Oxf)       Date:  2002-11       Impact factor: 3.478

View more
  20 in total

1.  Rapid Onset of Fatal Lactic Acidosis Complicating Tenofovir Therapy in a Diabetic Patient with Cirrhosis: A Cautionary Tale.

Authors:  Ramesh Kumar; Shivani Agrawal
Journal:  J Clin Exp Hepatol       Date:  2016-08-28

Review 2.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 3.  Hyperglycemic hyperosmolar nonketotic syndrome.

Authors:  R Venkatraman; Sunit C Singhi
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

Review 4.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

Review 5.  Managing hyperglycaemic emergencies: an illustrative case and review of recent British guidelines.

Authors:  Catherine F Gouveia; Tahseen A Chowdhury
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

6.  A case of hyperosmolar hyperglycaemic state with involuntary movements - diagnostic dilemma and clinical considerations.

Authors:  Hanisah Abd Hamid; Nor-Aini Umar; Hanita Othman; Srijit Das
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

Review 7.  Markers of Oxidative Stress during Diabetes Mellitus.

Authors:  Brahm Kumar Tiwari; Kanti Bhooshan Pandey; A B Abidi; Syed Ibrahim Rizvi
Journal:  J Biomark       Date:  2013-12-17

8.  Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Authors:  Katy E Trinkley; Heather D Anderson; Kavita V Nair; Daniel C Malone; Joseph J Saseen
Journal:  Ther Adv Chronic Dis       Date:  2018-06-13       Impact factor: 5.091

9.  Hyperglycemia increases susceptibility to ischemic necrosis.

Authors:  D Lévigne; M Tobalem; A Modarressi; B Pittet-Cuénod
Journal:  Biomed Res Int       Date:  2012-12-23       Impact factor: 3.411

10.  Hyperlactatemia associated with diabetic ketoacidosis in pediatric intensive care unit.

Authors:  Jingwei Liu; Haibo Yan; Yumei Li
Journal:  BMC Endocr Disord       Date:  2021-05-27       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.